Edition:
United Kingdom

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

3.19USD
14 Jun 2019
Change (% chg)

$-0.13 (-3.92%)
Prev Close
$3.32
Open
$3.30
Day's High
$3.30
Day's Low
$3.16
Volume
295,364
Avg. Vol
163,790
52-wk High
$7.35
52-wk Low
$1.45

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: --
Market Cap(Mil.): $96.98
Shares Outstanding(Mil.): 43.26
Dividend: --
Yield (%): --

Financials

  AFMD.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.99 -- --
ROI: -62.77 8.90 13.82
ROE: -67.79 10.04 15.24

Earnings vs. Estimates